CVS Well being (NYSE: CVS) will launch its newest quarterly outcomes and supply steering updates pre-market on Tuesday, Feb. 10. Over the previous 4 quarters, the healthcare large has delivered earnings outcomes that completed effectively forward of sell-side estimates. But even when CVS delivers a income and earnings beat in This autumn, do not assume that what comes subsequent is a post-earnings rally.
As a substitute, it is potential that updates to 2026 steering, affected by the latest proposed Medicare Benefit fee charges for this 12 months, will result in a damaging response amongst traders.
Will AI create the world’s first trillionaire? Our staff simply launched a report on the one little-known firm, known as an “Indispensable Monopoly” offering the crucial expertise Nvidia and Intel each want. Proceed »
This comes whilst this healthcare inventory has already been topic to near-term volatility on the Medicare information, falling by double-digit percentages upon its announcement late final month.
For This autumn 2025, sell-side consensus requires non-GAAP earnings of $0.99 per share. This represents a average decline from This autumn 2024, when the corporate reported non-GAAP earnings of $1.19 per share. That stated, walked-back expectations may give approach to one more earnings beat for CVS.
Then once more, it might not be the outcomes themselves that Wall Avenue focuses on with the earnings report coming subsequent week. As a substitute, a lot as with different main healthcare shares, traders could place larger concentrate on CVS’ 2026 steering.
They might significantly be wanting on the impact of the aforementioned Medicare Benefit fee charges on this steering. UnitedHealth (NYSE: UNH), which launched earnings the identical day the U.S. authorities proposed elevating Medicare Benefit fee charges by solely 0.9%, launched an underwhelming outlook for the approaching 12 months.
At the same time as CVS shares, which fell by over 14% on the Medicare Benefit information, could seem to already value within the impact of lower-than-expected fee will increase on income and profitability, that won’t essentially be the case. That stated, even when shares, which have began to bounce again from the latest sell-off, pattern decrease once more, do not assume this shatters CVS’ long-term bull case.
CVS shares could have offered off sharply on the Medicare Benefit information, however the firm’s future prospects could also be extra promising than UnitedHealth’s. Whereas UnitedHealth is primarily an insurance coverage firm, CVS’ Aetna unit makes up a smaller portion of its general enterprise.
